EX-99.1 2 dex991.htm PRESS RELEASE Press Release

Exhibit 99.1

LOGO

DANAHER REPORTS FOURTH QUARTER AND FULL YEAR 2008 RESULTS

WASHINGTON, D.C., January 26, 2009 — Danaher Corporation (NYSE:DHR) announced results for the fourth quarter and year ended December 31, 2008. Net earnings for the fourth quarter were $305.7 million, or $0.92 per diluted share. Included in the fourth quarter results are certain non-cash charges related to the acquisition of Tektronix for fair value adjustments to recorded inventory and deferred revenue which reduced net earnings by approximately $5 million or $0.01 per diluted share, as well as after-tax charges of approximately $62 million or $0.18 per diluted share related to previously announced restructuring activities. Absent these two items, adjusted earnings per diluted share was $1.11, essentially flat versus last year’s adjusted earnings per diluted share from continuing operations of $1.12.

Sales from continuing operations for the 2008 fourth quarter were $3.18 billion, 1% higher than the $3.14 billion reported for the 2007 fourth quarter.

Net earnings for the full year 2008 were $1.3 billion, or $3.95 per diluted share. Included in the full year 2008 earnings per diluted share are the fourth quarter 2008 items noted above, as well as the non-cash charges recorded in the first three quarters of 2008 related to the acquisition of Tektronix for fair value adjustments to recorded inventory and deferred revenue which reduced net earnings by approximately $0.12 per diluted share and gains from the net reduction in income tax reserves and discrete tax benefits of approximately $0.03 per diluted share. Absent these items, adjusted earnings per diluted share were $4.23, an increase of 10.5% compared to the 2007 full year adjusted earnings per diluted share from continuing operations of $3.83.

Sales from continuing operations for 2008 were $12.7 billion compared to $11 billion for 2007, an increase of 15%.

Attached is a reconciliation of adjusted diluted net earnings per share from continuing operations to diluted net earnings per share from continuing operations calculated according to GAAP, for the three and twelve month periods ended December 31, 2008 and the comparable prior year periods.

H. Lawrence Culp, Jr., President and Chief Executive Officer, stated, “The dramatic downturn in the global economy in the latter part of 2008 negatively impacted a number of our businesses, our end markets and our customers. In spite of these unprecedented headwinds we were able to deliver a solid 2008 performance. Core revenues decreased 1% in the quarter and increased 2.5% for the full year. Operating cash flow from continuing operations in 2008 was a record $1.9 billion, representing a 9.5% increase over our record 2007 performance. While we expect 2009 to be a difficult year, we believe our solid portfolio of businesses, our strong balance sheet and the Danaher Business System will provide our experienced team the opportunity to outperform.”

Danaher Corporation is a leading manufacturer of Professional Instrumentation, Medical Technologies, Industrial Technologies, and Tools and Components (www.danaher.com).

Statements in this release that are not strictly historical, including the statements regarding expectations for 2009 and any other statements regarding events or developments that we believe or anticipate will or may occur in the future, may be “forward-looking” statements. There are a number of important factors that could cause actual events to differ materially from those suggested or indicated by such forward-looking statements. These factors include, among other things, the current economic recession and the

 

1


upheaval in the credit markets and financial services industry, competition, our ability to develop and successfully market new products and technologies, our ability to expand our business in new markets, our ability to identify, consummate and integrate appropriate acquisitions, litigation and other contingent liabilities including intellectual property and environmental matters, our compliance with applicable laws and regulations and changes in applicable laws and regulations, tax audits and changes in our tax rate, currency exchange rates, commodity costs and surcharges, our relationships with and the performance of our channel partners, our ability to achieve projected efficiencies, cost reductions, sales growth and earnings, economic and other conditions in the end-markets we sell into, and general domestic and international economic conditions. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in our SEC filings, including our 2007 Annual Report on Form 10-K and Third Quarter 2008 Quarterly Report on Form 10-Q. These forward-looking statements speak only as of the date of this release and the Company does not assume any obligation or intend to update any forward-looking statement.

Please contact:

Andy Wilson

Vice President, Investor Relations

Danaher Corporation

2099 Pennsylvania Avenue

Washington, D.C. 20006

Telephone: (202) 828-0850

 

2


DANAHER CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF EARNINGS

($ in thousands, except per share amounts)

 

     Three Months Ended     Year Ended  
     12/31/08     12/31/07     12/31/08     12/31/07  

Sales

   $ 3,176,506     $ 3,141,177     $ 12,697,456     $ 11,025,917  

Operating costs and expenses:

        

Cost of sales

     1,724,897       1,690,647       6,757,262       5,985,022  

Selling, general and administrative expenses

     860,491       769,178       3,345,274       2,713,097  

Research and development expenses

     167,467       216,582       725,443       601,424  

Other (income) expense

     —         —         —         (14,335 )
                                

Total operating expenses

     2,752,855       2,676,407       10,827,979       9,285,208  

Operating profit

     423,651       464,770       1,869,477       1,740,709  

Interest expense

     (25,433 )     (32,793 )     (130,174 )     (109,702 )

Interest income

     4,000       2,735       10,004       6,092  
                                

Earnings from continuing operations before income taxes

     402,218       434,712       1,749,307       1,637,099  

Income taxes

     (96,532 )     (114,487 )     (431,676 )     (423,101 )
                                

Earnings from continuing operations

     305,686       320,225       1,317,631       1,213,998  

Earnings from discontinued operations, net of income taxes

     —         —         —         155,906  
                                

Net earnings

   $ 305,686     $ 320,225     $ 1,317,631     $ 1,369,904  
                                

Earnings per share from continuing operations:

        

Basic

   $ 0.96     $ 1.02     $ 4.13     $ 3.90  
                                

Diluted

   $ 0.92     $ 0.97     $ 3.95     $ 3.72  
                                

Earnings per share from discontinued operations:

        

Basic

     —         —         —       $ 0.50  
                                

Diluted

     —         —         —       $ 0.47  
                                

Net earnings per share:

        

Basic

   $ 0.96     $ 1.02     $ 4.13     $ 4.40  
                                

Diluted

   $ 0.92     $ 0.97     $ 3.95     $ 4.19  
                                

Average common stock and common equivalent shares outstanding:

        

Basic

     319,523       315,437       319,361       311,225  

Diluted

     333,593       334,013       335,863       329,459  

This information is presented for reference only. Final audited financial statements will include footnotes, which should be referenced when available, to more fully understand the contents of this information.

 

3


DANAHER CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

As of December 31 ($ and shares in thousands)

 

      2008     2007

ASSETS

    

Current Assets:

    

Cash and equivalents

   $ 392,854     $ 239,108

Trade accounts receivable, less allowance for doubtful accounts of $120,730 and $108,781, respectively

     1,894,585       1,984,384

Inventories

     1,142,309       1,193,615

Prepaid expenses and other current assets

     757,371       632,660
              

Total current assets

     4,187,119       4,049,767

Property, plant and equipment, net

     1,108,653       1,108,634

Other assets

     432,257       507,550

Goodwill

     9,210,581       9,241,011

Other intangible assets, net

     2,519,422       2,564,973
              

Total assets

   $ 17,458,032     $ 17,471,935
              

LIABILITIES AND STOCKHOLDERS’ EQUITY

    

Current Liabilities:

    

Notes payable and current portion of long-term debt

   $ 66,159     $ 330,480

Trade accounts payable

     1,108,961       1,125,600

Accrued expenses and other liabilities

     1,534,575       1,443,773
              

Total current liabilities

     2,709,695       2,899,853

Other long-term liabilities

     2,386,605       2,090,630

Long-term debt

     2,553,170       3,395,764

Stockholders’ equity:

    

Common stock—$0.01 par value, 1 billion shares authorized; 354,487 and 352,608 issued; 318,380 and 317,984 outstanding, respectively

     3,544       3,526

Additional paid-in capital

     1,812,963       1,718,716

Retained earnings

     8,095,155       6,820,756

Accumulated other comprehensive income

     (103,100 )     542,690
              

Total stockholders’ equity

     9,808,562       9,085,688
              

Total liabilities and stockholders’ equity

   $ 17,458,032     $ 17,471,935
              

This information is presented for reference only. Final audited financial statements will include footnotes, which should be referenced when available, to more fully understand the contents of this information.

 

4


DANAHER CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

Year Ended December 31 ($ in thousands)

 

     2008     2007  

Cash flows from operating activities:

    

Net earnings

   $ 1,317,631     $ 1,369,904  

Less: earnings from discontinued operations, net of tax

     —         155,906  
                

Net earnings from continuing operations

     1,317,631       1,213,998  

Non-cash items, net of the effect of discontinued operations:

    

Depreciation

     193,997       173,942  

Amortization

     145,290       94,550  

Stock compensation expense

     86,000       73,347  

Change in deferred income taxes

     27,691       29,870  

Change in trade accounts receivable, net

     71,403       (72,555 )

Change in inventories

     33,119       38,094  

Change in accounts payable

     3,713       103,800  

Change in prepaid expenses and other assets

     (4,773 )     38,601  

Change in accrued expenses and other liabilities

     (15,042 )     5,661  
                

Total operating cash flows from continuing operations

     1,859,029       1,699,308  

Total operating cash flows from discontinued operations

     —         (53,533 )
                

Net cash flows from operating activities

     1,859,029       1,645,775  
                

Cash flows from investing activities:

    

Payments for additions to property, plant and equipment

     (193,783 )     (162,071 )

Proceeds from disposals of property, plant and equipment

     1,088       15,537  

Cash paid for acquisitions

     (423,208 )     (3,576,562 )

Cash paid for investment in acquisition target and other marketable securities

     —         (23,219 )

Proceeds from sale of investment and divestitures

     —         301,278  

Proceeds from refundable escrowed purchase price

     48,504       —    
                

Total investing cash flows from continuing operations

     (567,399 )     (3,445,037 )

Total investing cash flows from discontinued operations

     —         (722 )
                

Net cash used in investing activities

     (567,399 )     (3,445,759 )
                

Cash flows from financing activities:

    

Proceeds from issuance of common stock

     82,430       733,028  

Payment of dividends

     (38,259 )     (34,275 )

Purchase of treasury stock

     (74,165 )     (117,486 )

Net (repayments) proceeds of borrowings (maturities of 90 days or less)

     (905,567 )     647,761  

Proceeds of borrowings (maturities longer than 90 days)

     72,652       493,705  

Repayments of borrowings (maturities longer than 90 days)

     (259,344 )     (10,563 )
                

Net cash (used in) generated by financing activities

     (1,122,253 )     1,712,170  
                

Effect of exchange rate changes on cash and equivalents

     (15,631 )     9,112  
                

Net change in cash and equivalents

     153,746       (78,702 )

Beginning balance of cash and equivalents

     239,108       317,810  
                

Ending balance of cash and equivalents

   $ 392,854     $ 239,108  
                

This information is presented for reference only. Final audited financial statements will include footnotes, which should be referenced when available, to more fully understand the contents of this information.

 

5


DANAHER CORPORATION AND SUBSIDIARIES

SEGMENT INFORMATION

($ in thousands, unaudited)

 

     Three Months Ended     Year Ended  
     12/31/08     12/31/07     12/31/08     12/31/07  

Sales

        

Professional Instrumentation

   $ 1,243,949     $ 1,097,511     $ 4,860,764     $ 3,537,912  

Medical Technologies

     843,820       866,311       3,277,026       2,997,986  

Industrial Technologies

     777,932       812,435       3,265,451       3,153,377  

Tools & Components

     310,805       364,920       1,294,215       1,336,642  
                                
   $ 3,176,506     $ 3,141,177     $ 12,697,456     $ 11,025,917  
                                

Operating Profit

        

Professional Instrumentation

   $ 221,960     $ 175,227     $ 907,254     $ 709,502  

Medical Technologies

     90,134       132,863       370,473       393,230  

Industrial Technologies

     106,569       132,046       522,112       532,477  

Tools & Components

     30,343       43,211       157,673       175,634  

Other

     (25,355 )     (18,577 )     (88,035 )     (70,134 )
                                
   $ 423,651     $ 464,770     $ 1,869,477     $ 1,740,709  
                                

Operating Margins

        

Professional Instrumentation

     17.8 %     16.0 %     18.7 %     20.1 %

Medical Technologies

     10.7 %     15.3 %     11.3 %     13.1 %

Industrial Technologies

     13.7 %     16.3 %     16.0 %     16.9 %

Tools & Components

     9.8 %     11.8 %     12.2 %     13.1 %

Total

     13.3 %     14.8 %     14.7 %     15.8 %

Restructuring & Other Related Charges

        

Professional Instrumentation

   $ 28,813       —       $ 28,813       —    

Medical Technologies

     26,081       —         26,081       —    

Industrial Technologies

     23,093       —         23,093       —    

Tools & Components

     3,978       —         3,978       —    
                                

Total

   $ 81,965       —       $ 81,965       —    
                                

Restructuring Cost Classification

        

Cost of sales

   $ 33,130       —       $ 33,130       —    

Selling, general and administrative expenses

     48,835       —         48,835       —    
                                
   $ 81,965       —       $ 81,965       —    
                                

This information is presented for reference only. Final audited financial statements will include footnotes, which should be referenced when available, to more fully understand the contents of this information

 

6


Danaher Corporation

Supplemental Reconciliation of Net Earnings from Continuing Operations and Diluted Net Earnings

Per Share from Continuing Operations (GAAP) to Adjusted Net Earnings from Continuing

Operations and Adjusted Diluted Net Earnings Per Share from Continuing Operations (Non-GAAP)

Three Months and Years Ended December 31, 2008 and December 31, 2007

($ in 000’s except per share data)

 

     Three Months Ended           Years Ended        
     December 31,
2008
    December 31,
2007
    %
Change
    December 31,
2008
    December 31,
2007
    %
Change
 

Net Earnings from Continuing Operations per GAAP

   $ 305,686     $ 320,225     -4.5 %   $ 1,317,631     $ 1,213,998     8.5 %
                    

After-tax charges for purchased in-process research and development and fair value adjustments to recorded inventory and deferred revenue balances related to the acquisition of Tektronix ($6.9 million & $59.5 million pre-tax for the three months and year ended December 31, 2008, respectively, and $68.2 million for both the three months and year ended December 31, 2007)

     5,150       66,000         44,465       66,000    

After-tax charge related to fourth quarter 2008 restructuring actions and related charges ($82.0 million pre-tax).

     61,500       —           61,500       —      

Gains from net reduction in income tax reserves and discrete tax benefits

     (1,160 )     (14,562 )       (9,524 )     (21,084 )  

After-tax gain on indemnity proceeds related to litigation matter ($12.5 million pre-tax)

     —         —           —         (8,110 )  
                                    

Adjusted Net Earnings from Continuing Operations (Non-GAAP)

   $ 371,176     $ 371,663     -0.1 %   $ 1,414,072     $ 1,250,804     13.1 %
                                            

Diluted Net Earnings Per Share from Continuing Operations per GAAP

   $ 0.92     $ 0.97     -5.2 %   $ 3.95     $ 3.72     6.2 %
                    

After-tax charges for purchased in-process research and development and fair value adjustments to recorded inventory and deferred revenue balances related to the acquisition of Tektronix ($6.9 million & $59.5 million pre-tax for the three months and year ended December 31, 2008, respectively, and $68.2 million for both the three months and year ended December 31, 2007)

     0.01       0.20         0.13       0.20    

After-tax charge related to fourth quarter 2008 restructuring actions and related charges ($82.0 million pre-tax).

     0.18       —           0.18       —      

Gains from net reduction in income tax reserves and discrete tax benefits

     —         (0.05 )       (0.03 )     (0.07 )  

After-tax gain on indemnity proceeds related to litigation matter ($12.5 million pre-tax)

     —         —           —         (0.02 )  
                                    

Adjusted Diluted Net Earnings Per Share from Continuing Operations (Non-GAAP)

   $ 1.11     $ 1.12     -0.9 %   $ 4.23     $ 3.83     10.4 %
                                            

 

7


Danaher Corporation

Supplemental Reconciliation of Revenue Growth (GAAP) to Revenue Growth from Existing Businesses (Non-GAAP)

Three Months Ended December 31, 2008 and December 31, 2007

 

      Three Months Ended
December 31, 2008 vs.
Comparable 2007
Period
    Year Ended
December 31, 2008 vs.
Comparable 2007
Period
 

Components of Sales Growth

    

Existing Businesses

   -1.0 %   2.5 %

Acquisitions

   6.0 %   10.5 %

Impact of currency translation

   -4.0 %   2.0 %
            

Total

   1.0 %   15.0 %
            

Notes to Non-GAAP Reconciliation Schedule

General

In addition to the results provided in this release in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”), the Company has provided the following non-GAAP measures:

(1) Adjusted net earnings from continuing operations for the three months and year ended December 31, 2008 and December 31, 2007 and adjusted net earnings from continuing operations per diluted share for the three months and year ended December 31, 2008 and December 31, 2007. These measures are calculated on a basis which:

 

   

in the 2008 period, exclude (a) certain non-cash charges related to the acquisition of Tektronix, Inc. for fair value adjustments to recorded inventory and deferred revenue balances, (b) gains related to a reduction of income tax reserves and discrete tax benefits and (c) charges related to fourth quarter 2008 restructuring actions and related charges; and

 

   

in the 2007 period, exclude (a) gains related to a reduction of income tax reserves and discrete tax benefits, and (b) the gain on indemnity proceeds received in connection with a litigation matter and (c) certain non-cash charges for purchased in-process research and development and fair value adjustments to recorded inventory and deferred revenue balances related to the acquisition of Tektronix.

The Company also discloses the year-over-year percentage change in these non-GAAP measures. Collectively, these non-GAAP measures are referred to as the “non-GAAP earnings measures”.

(2) Core revenue growth from existing businesses (presented on a stand-alone basis), which is defined as revenue growth from businesses that have been owned for one year or more, excluding the effects of foreign currency fluctuations.

The non-GAAP measures should be considered in addition to, and not as a replacement for or superior to, the comparable GAAP measures. Danaher’s non-GAAP measures may be defined differently than similar non-GAAP measures that are used by other companies.

Non-GAAP earnings measures and revenue growth from existing businesses

Danaher’s management believes that the non-GAAP earnings measures and revenue growth from existing businesses reflect additional ways of viewing aspects of Danaher’s operations that, when viewed with and reconciled to the corresponding GAAP measures, provide a more complete understanding of Danaher’s results of

 

8


operations and help identify underlying trends in Danaher’s business. The items that have been excluded from the non-GAAP earnings measures have been excluded because items of this nature and size occur with inconsistent frequency and for reasons that may be unrelated to Danaher’s commercial performance during the period, and we believe are not indicative of Danaher’s ongoing operating costs or gains in a given period. Similarly, revenue growth from existing businesses excludes items that are not completely under management’s control, such as the impact of changes in foreign currency exchange rates, and items that do not reflect the underlying growth of the company, such as acquisition and divestiture activity.

Danaher’s management uses these non-GAAP measures in assessing current performance against prior period performance and against forecasted performance, in forecasting financial results for future periods, and in making decisions about internal budgets, resource allocation and financial goals for its business units. Danaher’s management believes that these non-GAAP measures help investors and others, if they so choose, in understanding and evaluating Danaher’s current operating performance and future prospects in the same manner as management does. In addition, Danaher believes that analysts and others in the investment community use these non-GAAP measures to assess Danaher’s performance against prior period performance and against forecasted performance, compare Danaher’s performance to the performance of our peer companies, identify trends in Danaher’s performance and provide estimates of future performance.

A general limitation of these non-GAAP measures is that use of these measures (as compared to the related GAAP measures of net earnings from continuing operations, revenue and revenue growth) may reduce comparability with other companies who may calculate similar non-GAAP measures differently. A particular limitation of the non-GAAP earnings measures is that they exclude charges that can significantly affect Danaher’s results of operations and that may recur in the course of Danaher’s business (though at times and in amounts that may be difficult to predict). Similarly, a particular limitation of revenue growth from existing businesses is that it excludes items that can significantly impact our revenues. Danaher management compensates, and believes that investors should compensate, for these and other limitations of these non-GAAP measures by also considering Danaher’s financial results as determined in accordance with GAAP, including the GAAP measures described above in this paragraph.

 

9